Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Effect of hepatic impairment on the pharmacokinetics of vilaprisan: An open-label, single-dose, parallel-group study.

Chattopadhyay N, Riecke K, Ligges S, Zimmermann T, Halabi A, Schultze-Mosgau MH.

Br J Clin Pharmacol. 2019 Sep;85(9):2011-2021. doi: 10.1111/bcp.13992. Epub 2019 Jul 10.

2.

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia.

Steurer M, Montillo M, Scarfò L, Mauro FR, Andel J, Wildner S, Trentin L, Janssens A, Burgstaller S, Frömming A, Dümmler T, Riecke K, Baumann M, Beyer D, Vauléon S, Ghia P, Foà R, Caligaris-Cappio F, Gobbi M.

Haematologica. 2019 Oct;104(10):2053-2060. doi: 10.3324/haematol.2018.205930. Epub 2019 May 16.

3.

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.

Ludwig H, Weisel K, Petrucci MT, Leleu X, Cafro AM, Garderet L, Leitgeb C, Foa R, Greil R, Yakoub-Agha I, Zboralski D, Vauléon S, Dümmler T, Beyer D, Kruschinski A, Riecke K, Baumann M, Engelhardt M.

Leukemia. 2017 Apr;31(4):997-1000. doi: 10.1038/leu.2017.5. Epub 2017 Jan 11. No abstract available.

4.

Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects.

Boyce M, Warrington S, Cortezi B, Zöllner S, Vauléon S, Swinkels DW, Summo L, Schwoebel F, Riecke K.

Br J Pharmacol. 2016 May;173(10):1580-8. doi: 10.1111/bph.13433. Epub 2016 Apr 8.

5.

Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.

Laakmann E, Riecke K, Goy Y, Kersten JF, Krüll A, Müller V, Petersen C, Witzel I.

J Cancer Res Clin Oncol. 2016 Jan;142(1):325-32. doi: 10.1007/s00432-015-2049-4. Epub 2015 Sep 30.

PMID:
26424693
6.

Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans.

van Eijk LT, John AS, Schwoebel F, Summo L, Vauléon S, Zöllner S, Laarakkers CM, Kox M, van der Hoeven JG, Swinkels DW, Riecke K, Pickkers P.

Blood. 2014 Oct 23;124(17):2643-6. doi: 10.1182/blood-2014-03-559484. Epub 2014 Aug 27.

7.

Effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin on the extracellular matrix of the thymus in juvenile marmosets (Callithrix jacchus).

Nottebrock C, Riecke K, Kruse M, Shakibaei M, Stahlmann R.

Toxicology. 2006 Sep 21;226(2-3):197-207. Epub 2006 Jul 14.

PMID:
16920245
8.

Sensitising potential of four textile dyes and some of their metabolites in a modified local lymph node assay.

Stahlmann R, Wegner M, Riecke K, Kruse M, Platzek T.

Toxicology. 2006 Feb 15;219(1-3):113-23. Epub 2006 Jan 4.

PMID:
16388883
9.

An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: first round.

Ehling G, Hecht M, Heusener A, Huesler J, Gamer AO, van Loveren H, Maurer T, Riecke K, Ullmann L, Ulrich P, Vandebriel R, Vohr HW.

Toxicology. 2005 Aug 15;212(1):60-8.

PMID:
15950356
10.

An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: 2nd round.

Ehling G, Hecht M, Heusener A, Huesler J, Gamer AO, van Loveren H, Maurer T, Riecke K, Ullmann L, Ulrich P, Vandebriel R, Vohr HW.

Toxicology. 2005 Aug 15;212(1):69-79. Epub 2005 Feb 12.

PMID:
15878228
11.

Effects of 2,3,7,8-TCDD and PCB 126 on human thymic epithelial cells in vitro.

Riecke K, Schmidt A, Stahlmann R.

Arch Toxicol. 2003 Jun;77(6):358-64. Epub 2003 Mar 7.

PMID:
12799776
12.

Low doses of 2,3,7,8-tetrachlorodibenzo- p-dioxin increase transforming growth factor beta and cause myocardial fibrosis in marmosets ( Callithrix jacchus).

Riecke K, Grimm D, Shakibaei M, Kossmehl P, Schulze-Tanzil G, Paul M, Stahlmann R.

Arch Toxicol. 2002 Jun;76(5-6):360-6. Epub 2002 Apr 11.

PMID:
12107654
13.

Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats.

Lozo E, Riecke K, Schwabe R, Vormann J, Stahlmann R.

Antimicrob Agents Chemother. 2002 Jun;46(6):1755-9.

14.

[Well tolerated or risky? Adverse effect of quinolones].

Stahlmann R, Riecke K.

Pharm Unserer Zeit. 2001;30(5):412-7. Review. German. No abstract available.

PMID:
11575178
15.

Cross-reactivity of antibodies on thymic epithelial cells from humans and marmosets by flow-cytometry.

Riecke K, Nogueira AC, Alexi-Meskishvili V, Stahlmann R.

J Med Primatol. 2000 Oct;29(5):343-9.

PMID:
11168825
16.

Developmental toxicity of the HIV-protease inhibitor indinavir in rats.

Riecke K, Schulz TG, Shakibaei M, Krause B, Chahoud I, Stahlmann R.

Teratology. 2000 Nov;62(5):291-300.

PMID:
11029147
17.

Test systems to identify reproductive toxicants.

Riecke K, Stahlmann R.

Andrologia. 2000 Sep;32(4-5):209-18. Review.

PMID:
11021511
18.

[Inpatient treatment costs of exacerbated chronic obstructive lung disease].

Riecke K, Eller J, Gericke C, Lode H.

Pneumologie. 1999 Apr;53(4):199-206. German.

PMID:
10409862
19.

[Pulmonary melioidosis in a German Southeast Asia tourist].

Riecke K, Wagner S, Eller J, Lode H, Schaberg T.

Pneumologie. 1997 May;51(5):499-502. German.

PMID:
9265152

Supplemental Content

Loading ...
Support Center